K7B763 (K7B763_PANTR) Pan troglodytes (Chimpanzee)
Tyrosine-protein kinase UniProtKBInterProInteractive Modelling
536 aa; Sequence (Fasta) ;
3 identical sequences: Homo sapiens: P12931; Pan troglodytes: A0A6D2Y674; Gorilla gorilla gorilla: G3QWW0
It is possible new templates exist for this target since these models were created.
Available Structures
70 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of SH3:RGT complex |
Heteromer P05106; P12931; | |||||
| Assess | ||||||
| Src-derived mutant peptide inhibitor complex of PTP1B |
Heteromer P12931; P18031; | |||||
| Assess | ||||||
| Crystal structure of the tyrosine kinase binding domain of Cbl-c in complex with phospho-Src peptide |
Heteromer P12931; Q9ULV8; | 1×CA; | ||||
| Assess | ||||||
| PTPN21 PTP domain C1108S mutant in complex with SRC pTyr530 peptide |
Heteromer P12931; Q16825; | |||||
| Assess | ||||||
| Src-derived peptide inhibitor complex of PTP1B |
Heteromer P12931; P18031; | |||||
| Assess | ||||||
| C-Src in complex with compound 9 | homo-2-mer | 2×C0N; | ||||
| Assess | ||||||
| C-src (SH2 domain) complexed with ace-formyl phosphotyr-glu-(n,n-dipentyl amine) | homo-2-mer | |||||
| Assess | ||||||
| C-SRC (SH2 DOMAIN WITH C188A MUTATION) COMPLEXED WITH ACE-FORMYL PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) | homo-2-mer | |||||
| Assess | ||||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) | homo-2-mer | |||||
| Assess | ||||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-MALONYL TYR-GLU-(N,N-DIPENTYL AMINE) | homo-2-mer | |||||
| Assess | ||||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(N-ME(-(CH2)3-CYCLOPENTYL)) | homo-2-mer | |||||
| Assess | ||||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-PHOSPHOTYR-GLU-(3-BUTYLPIPERIDINE) | homo-2-mer | |||||
| Assess | ||||||
| Human cSrc SH3 Domain in complex with Choline Kinase fragment 60-69 | homo-2-mer | 2×ZN; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC | monomer | |||||
| Assess | ||||||
| Structure of unphosphorylated c-Src in complex with an inhibitor | monomer | 5×SO4; 1×MPZ; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN TYROSINE-PROTEIN KINASE C-SRC, IN COMPLEX WITH AMP-PNP | monomer | 1×ANP; | ||||
| Assess | ||||||
| Structure of Human c-Src Tyrosine Kinase (Thr338Gly Mutant) in Complex with N6-benzyl ADP | monomer | 1×NBS; | ||||
| Assess | ||||||
| The structure of 1NA in complex with Src T338G | monomer | 1×0J9; | ||||
| Assess | ||||||
| Src kinase in complex with a quinazoline inhibitor | monomer | 1×H8H; | ||||
| Assess | ||||||
| Crystal structure of Src kinase domain in complex with Purvalanol A | monomer | 1×P01; | ||||
| Assess | ||||||
| Crystal structure of Src kinase domain in complex with CGP77675 | monomer | 1×S03; | ||||
| Assess | ||||||
| Src kinase bound to eCF506 trapped in inactive conformation | monomer | 1×EDO; 1×UCW; | ||||
| Assess | ||||||
| human Src kinase bound to kinase inhibitor bosutinib | monomer | 1×DB8; | ||||
| Assess | ||||||
| The complex of Src with GW8510 | monomer | 1×L1N; | ||||
| Assess | ||||||
| SRC kinase bound to covalent inhibitor | monomer | 1×6H3; | ||||
| Assess | ||||||
| Src M314L T338M double mutant bound to kinase inhibitor bosutinib | monomer | 1×DB8; | ||||
| Assess | ||||||
| Src M314L T338M double mutant bound to kinase inhibitor bosutinib | monomer | 1×DB8; | ||||
| Assess | ||||||
| Human Src A403T mutant bound to kinase inhibitor bosutinib | monomer | 1×DB8; | ||||
| Assess | ||||||
| C-term tail segment of human tyrosine kinase (258-533) | monomer | |||||
| Assess | ||||||
| DGY-06-116, a novel and selective covalent inhibitor of SRC kinase | monomer | 1×HVY; | ||||
| Assess | ||||||
| Src Kinase Domain in complex with ponatinib | monomer | 1×0LI; 1×TRS; 4×GOL; | ||||
| Assess | ||||||
| Crystal structure of Src kinase domain | monomer | |||||
| Assess | ||||||
| Src kinase in complex with inhibitor AP23451 | monomer | 1×24A; | ||||
| Assess | ||||||
| Src kinase in complex with inhibitor AP23464 | monomer | 1×HET; | ||||
| Assess | ||||||
| Structure of human SRC regulatory domains in complex with the C-terminal PRRP motifs of GPR54. | monomer | |||||
| Assess | ||||||
| Triple mutant Src SH2 domain bound to phosphotyrosine | monomer | 1×PTR; | ||||
| Assess | ||||||
| Triple mutant Src SH2 domain | monomer | |||||
| Assess | ||||||
| Triple mutant Src SH2 domain bound to phosphate ion | monomer | 1×PO4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82197. | monomer | 1×197; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82129. | monomer | 1×821; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053. | monomer | 1×853; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH DPI59. | monomer | 1×I59; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PASBN. | monomer | 1×PSN; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH OXALIC ACID. | monomer | 1×OXD; | ||||
| Assess | ||||||
| Crystal structure of sh2 in complex with ru85052 | monomer | 1×852; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH ISO24. | monomer | 1×IS2; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU81843. | monomer | 1×843; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79256. | monomer | 1×256; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85493. | monomer | 1×493; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHENYLPHOSPHATE. | monomer | 2×HPS; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78300. | monomer | 1×300; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PAS219. | monomer | 1×219; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU84687. | monomer | 1×687; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU82209. | monomer | 1×822; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU83876. | monomer | 1×876; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78299. | monomer | 1×299; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU90395. | monomer | 1×903; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79072. | monomer | 1×772; | ||||
| Assess | ||||||
| NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX | monomer | |||||
| Assess | ||||||
| NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX | monomer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78783. | monomer | 1×787; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH MALONICACID. | monomer | 1×MLA; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH FRAGMENT2. | monomer | 1×CIT; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH PHOSPHATE. | monomer | 1×PO4; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78262. | monomer | 1×262; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU78791. | monomer | 1×791; | ||||
| Assess | ||||||
| PEPTIDE INHIBITORS OF SRC SH3-SH2-PHOSPHOPROTEIN INTERACTIONS | monomer | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU79073. | monomer | 1×790; | ||||
| Assess | ||||||
| C-SRC (SH2 DOMAIN) COMPLEXED WITH ACE-DIFLUORO PHOSPHOTYR-GLU-(N,N-DIPENTYL AMINE) | monomer | |||||
| Assess | ||||||
| Crystal structure of a superbinder Src SH2 domain (sSrcF) in complex with a high affinity phosphope… | monomer | 1×ZN; | ||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 2h8h.1.A | monomer | 0.83 | 1×H8H; | 100.00 | ||
| Assess | ||||||
| 1y57.1.A | monomer | 0.82 | 1×MPZ; | 100.00 | ||
| Assess | ||||||